Table 3.

Differences between parameters detected at 2 different times in the case and control groups and p value of comparing data between these two groups. The values are reported as mean ± standard deviation (range).

Parameter	MAS	Control	p value
WBC1-WBC2 (×103/uL)	7337 ± 11572 (−19030 to 34191)	781.04 ± 9243 (−24000 to 43500)	0.004
WBC3-WBC2 (×103/uL)	8284 ± 14647 (−19640 to 44070)	−5593 ± 7941 (−28800 to 9830)	0.00
PMN1-PMN2 (×103/uL)	4888–10049 (−16228 to 31407)	−137 ± 6127 (−16908 to 12555)	0.02
PMN3-PMN2 (×103/uL)	6404 ± 9787 (−3750 to 29622)	−6167 ± 6288 (−21261 to 3572)	<0.001
Lymph1-Lymph2 (×103/uL)	1277 ± 5889 (−11763 to 17670)	381.78 ± 4864 (−6972 to 28278)	0.07
Lymph3-Lymph2 (×103/uL)	1484 ± 2505 (−1151 to 6560)	135.45 ± 2504 (−6927 to 8025)	0.1
Hgb1-Hgb2 (g/dL)	1.24 ± 1.34 (−1.10 to 4.20)	0.067 ± 1.38 (−2.50 to 2.90)	0.008
Hgb3-Hgb2 (g/dL)	1.17 ± 1.45 (−1.50 to 3.10)	1.17 ± 1.75 (−2.40 to 5.10)	0.8
PLT1-PLT2 (/microliter)	190176 ± 176530 (11000–485000)	−2826 ± 176163 (−377000 to 353000)	0.001
PLT3-PLT2 (/microliter)	217785 ± 194694 (−2000 to 75800)	−90864 ± 164212 (−633000 to 140000)	<0.001
ESR1-ESR2 (mm/h)	28 ± 35 (−40 to 84)	2.65 ± 35.53 (−70 to 74)	0.03
ESR3-ESR2 (mm/h)	3.5 ± 60 (−91 to 155)	49.68 ± 40.11 (−42 to 115)	0.002
CRP1-CRP2 (mg/L)	97.11 ± 93.75 (20 to 303)	27.61 ± 83.73 (−174 to 252)	0.003
CRP3-CRP2 (mg/L)	116.95 ± 115.22 (0 to 299)	80.20 ± 64.38 (21.60 to 269)	0.5

MAS: Macrophage Activation Syndrome, WBC: white blood cells, PMN: polymorphonuclear, Lymph: lymphocytes, Hgb: hemoglobin, PLT: platelet, ESR: erythrocyte sedimentation rate, and CRP: C-reactive protein. The previous laboratory records: WBC1, PMN1, and so forth. The laboratory data at the onset of MAS (MAS group) or active rheumatologic disease (control group): WBC2, PMN2, and so forth. The laboratory data 1 month after discharge from the hospital: WBC3, PMN3, and so forth.